MICHAEL WHITE to Protein Kinase Inhibitors
This is a "connection" page, showing publications MICHAEL WHITE has written about Protein Kinase Inhibitors.
Connection Strength
0.370
-
A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells. Sci Rep. 2018 02 28; 8(1):3770.
Score: 0.103
-
Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma. Cancer Discov. 2017 08; 7(8):832-851.
Score: 0.097
-
Cutting Edge: Inhibiting TBK1 by Compound II Ameliorates Autoimmune Disease in Mice. J Immunol. 2015 Nov 15; 195(10):4573-7.
Score: 0.087
-
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. Nature. 2022 06; 606(7915):797-803.
Score: 0.035
-
The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies. Nat Commun. 2017 02 16; 8:14356.
Score: 0.024
-
SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers. Nat Commun. 2017 01 19; 8:14098.
Score: 0.024